To protect our staff and visitors from COVID-19, OPA office staff will work remotely. We’ll continue to be fully operational to serve our members. Contact us at 416-441-0788 or 1-877-341-0788 or mail@opatoday.com.

Publications

  • eDIRC: Prevention of Migraines in Adults

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    April 25, 2019 volume 17 no 9

  • OPA Bulletin - April 23, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Announcement to expand scope of practice for pharmacists generates public discussion
    • Apply to the Allied Health Professional Development Fund for Compensation of Conference Fees
    • OPA Celebrates National Immunization Awareness Week with Record Breaking Year for Flu Shots
    • Attention Pharmacies in Timmins, Cornwall, Kapuskasing and Thunder Bay - Potential Increase in NIHB Claims

    • An Update On Oral Anticoagulation
    • Managing Your Pharmacy: The Business Essentials
    • Assessing and Prescribing for Minor Ailments - Full Program

    • Meet the Future Leaders in Research at PxP2019
    • Ask the Customer Experience and Administration Team

    • Ask Us Your Questions on Critical Illness

    • ODB Formulary – Edition No. 43, Summary of Changes – April 2019 Summary of Product Changes

    • Auro Pharma Inc. voluntarily recalls one lot of Auro-Irbesartan HCT tablets because of nitrosamine impurity
    • Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation

  • OPA Bulletin - April 16, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: Provincial Budget Announces Expansion of Scope of Practice for Pharmacists
    • Conference Early Bird Deadline is Thursday
    • Express Scripts Canada - Pharmacy Provider Manual

    • Take-home Naloxone in Community Pharmacies
    • Methadone and Buprenorphine/ Naloxone Toolkit
    • Opioid Addictions and Substitution Therapy Online Modules

    • PxP2019 Conference Social Events
    • Ask the Practice Support Network

    • Are You Prepared for a Critical Illness?

    • DDD Notice No. 19062 posted April 12, 2019 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Zinecard (Dexrazoxane)
    • Health Canada approves updates to Mifegymiso prescribing information

  • eDIRC: OCP-Recognized Cannabis Education Program Available Now!

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    April 11, 2019 volume 17 no 8

  • OPA Bulletin - April 09, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OHIP+ Update
    • Conference Early Bird Deadline is April 18
    • Patient Tip Sheet - Managing a Diet While Taking Warfarin
    • April is IBS Awareness Month - Read our Blog Post for Pharmacists
    • Ontario College of Pharmacists Annual Report

    • NEW! Medical Devices Training for Pharmacy Technicians
    • Collaboration with Family Physicians: the Rx for Success
    • FAQs and a New Drug Update on Contraception and Abortion Care
    • Potential Funding Available for OPA Professional Development

    • Time-Limited WebCrasher Savings with OPA Partner, Dell
    • PxP2019 Speaker Spotlight: Women's Health, Polypharmacy and T2D
    • OPA Supports Partner in Naloxone Awareness Day at Queen's Park
    • Ask the Customer Experience and Administration Team

    • OPA Advantage Plus
    • Last Chance for Movie Tickets from COSECO

    • Drug Shortage / Supply Health System Alert: Dexrazoxane, Erwinia Asparaginase and Etoposide

    • Biocell breast implants - Information Update
    • BENLYSTA (belimumab) - Safety Alert

  • OPA Bulletin - April 02, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA Launches CCCEP-accredited and OCP-approved Cannabis Program for Pharmacists
    • Additonal OHIP+ Resources
    • CPhA survey on ARB recalls and drug shortages
    • Canadian Foundation for Pharmacy's Innovation Showcase is April 23
    • Women in Pharmacy Leadership Summit: What's on your mind?
    • And the winner of the OPA Cup is ...

    • NEW for Pharmacy Technicians! Identifying Drug Interactions
    • NEW for Pharmacists! Paid Consultations - Opportunities and Timesavers
    • Drugs in Chronic Kidney Disease: Implications for Pharmacists

    • Thank You to Those Who Submitted an OPA Award Nomination
    • PxP2019 Announces Keynote Speakers
    • Ask the Practice Support Network

    • Stay Insured When Leaving the Country with OPA's Emergency Travel Insurance
    • It's Movie Ticket Time with COSECO!

    • March Issue of Health Product InfoWatch Now Available

  • eDIRC: OHIP+: OPA Process Map and Pharmacy Tool

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    March 28, 2019 volume 17 no 7

  • OPA Bulletin - March 26, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA Process Map and Pharmacy Tool for OHIP+
    • ICYMI: Empowering Canadian Pharmacy Practice
    • Pharmacy Experience Pharmacie 2019 is open for registration!
    • Research Study: The Ontario Digital Service and Ministry of Health and Long-Term Care
    • Canadian Federation of Pharmacy Campaign Drive 1 Million for 25
    • OPA Supports Broader Discussion on Impact of Removal of Private Label Ban

    • Implementing Smoking Cessation Services in the Pharmacy
    • Asthma Management: The Essentials
    • MedsCheck Refresh: Implementing the Revitalized Program

    • Last Call for OPA Awards
    • Ask the Customer Experience and Administration Team

    • OPA Secure Health Plan Q&A
    • It's Movie Ticket Time with COSECO!

    • DDD Notice No. 19057 posted March 20, 2019 Prescription Forgery Alert
    • DDD Notice No. 19058 posted March 21, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – March 2019
    • DDD Notice No. 19059 posted March 25, 2019 Claim Submission/Reversal and Special Authorization (Allergen) forms

    • Extraneal peritoneal dialysis solution - Advisory
    • Important Safety Information on DARZALEX (daratumumab) and Hepatitis B Virus Reactivation - Janssen Inc.

  • OPA Bulletin - March 19, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Preparing for OHIP+ Amendments
    • Federal Budget Promises Funding for Key Healthcare Areas
    • Assessing Barriers to High Quality Care for Diabetes Patients Across Ontario
    • ICYMI: OPA Answers Your Questions on Pharmacy in 2019 and Beyond

    • Board Certified Geriatric Pharmacist (BCGP) Preparation Course – Medication Therapy Management for Older Adults
    • How To: Ontario's Pharmaceutical Opinion Program
    • The MASTER Plan for Diabetes Continuing Education Program

    • ICYMI: OPA Board Members Speak Out on Membership with OPA
    • Ask the Practice Support Network

    • Are You Insured Through Your Employer's Group Plan for Long-Term Disability (LTD)?
    • It's Movie Ticket Time with COSECO!

    • DDD Notice No. 19047 posted March 13, 2019 Prescription Forgery Alert
    • DDD Notice No. 19048 posted March 13, 2019 Notice from the Executive Officer: Buprenorphine/ Naloxone (Suboxone® and generics) Reimbursement Reminder under the Ontario Drug Benefit Program
    • DDD Notice No. 19049 posted March 13, 2019 OHIP+ FAQs for Patients and Pharmacists
    • DDD Notice No. 19053 posted March 15, 2019 CPSO Notices, February 2019
    • DDD Notice No. 19055 posted March 18, 2019 HEALTH NETWORK SYSTEM (HNS) AND NARCOTICS MONITORING SYSTEM (NMS) OUTAGES NOTIFICATION TO ODP AGENCIES
    • DDD Notice No. 19056 posted March 19, 2019 Prescription Forgery Alert
    • Delay in NIHB Provider Payments

    • Xeljanz and Xeljanz XR (tofacitinib) - Information Update
    • Irbesartan - Information Update
    • TECENTRIQ (atezolizumab) - Important Safety Information

  • eDIRC: OHIP+: NEW Materials for Pharmacists and Patients

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    March 14, 2019 volume 17 no 6

  • OPA Bulletin - March 12, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Ministry Releases Patient and Pharmacist Materials for OHIP+
    • Statement from the Chief Public Health Officer of Canada, Dr. Theresa Tam, on the current measles outbreak and vaccine hesitancy
    • Announcement from Indigenous Services Canada: Non-Insured Health Benefits (NIHB) Program - Coverage of Inhalers for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
    • Interim Report on Pharmacare Released
    • OPA Queen's Park Day - March 7, 2019
    • CPhA Launches Women in Pharmacy Leadership Initiative

    • Paid Consultations: Opportunities and Timesavers
    • FAQs and a New Drug Update on Contraception and Abortion Care
    • Identifying Drug Interactions

    • Countdown to OPA Awards!
    • Ask the Customer Experience and Administration Team
    • Next OPA Webinar Wednesday Night

    • Are You Prepared for a Critical Illness?
    • It's Movie Ticket Time with COSECO!

    • DDD Notice No. 19044 posted March 06, 2019 Prescription Forgery Alert
    • DDD Notice No. 19045 posted March 06, 2019 Prescription Forgery Alert

    • Recall - Multiple Losartan-containing drugs - Information Update

  • OPA Bulletin - March 5, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA Q&A on OHIP+ for Children and Youth
    • New Horizons in Pharmacy - Register for OPA webinar
    • OPA Queen's Park Day - March 7, 2019
    • Call for Applications for Canadian Foundation for Pharmacy 2019 Innovation Fund
    • Save the Date - Canadian Foundation for Pharmacy Innovation Showcase, Building Bridges for Better Care

    • FREE Opioid Addictions and Substitution Therapy Webinars
    • Third Party Audit: An Introduction
    • Personal Branding for Pharmacy Professionals

    • Countdown to OPA Awards!
    • Pharmacist Awareness Month Kicks Off at U of T
    • Ask the Practice Support Network

    • Buying or selling a pharmacy? How does this affect your insurance?
    • It's Movie Ticket Time with COSECO!

    • DDD Notice No.19039 posted February 27, 2019 Amendment to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act to make changes to Ontario Drug Benefit Program coverage for children and youth aged 24 years and under (OHIP+)
    • DDD Notice No.19040 posted February 28, 2019 Notice from the Executive Officer
    • DDD Notice No. 19041 posted March 04, 2019 Prescription Forgery Alert
    • IMPORTANT: Drug Shortage Notification - DEMULEN 30

  • eDIRC: New Amendment to OHIP+ Benefits

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    February 28, 2019 volume 17 no 5

  • OPA Bulletin - February 26, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Ministry of Health and Long-Term Care proposes "Ontario Health"
    • New Horizons in Pharmacy - Register for OPA webinar
    • Weekly webinars on OHIP+ program launch April 1, 2019

    • FAQs and a New Drugs Update on Contraception and Abortion Care
    • Rational Prescribing - Re-thinking Medications
    • Delivering a Comprehensive Pharmacy-based Vaccines Program

    • March is Pharmacist Awareness Month - look who's representing
    • Ask the Customer Experience and Administration Team
    • Insurance Highlight: Deadline to purchase an Extended Reporting Period on your expired PLI policy is approaching

    • DDD Notice No. 19036 ODB Formulary – Edition No. 43, Summary of Changes – February 2019
    • DDD Notice No. 19037 posted February 22, 2019 Prescription Forgery Alert
    • DDD Notice No. 19038 posted February 22, 2019 Prescription Forgery Alert
    • Drug Supply Health System Alert: Epipen Auto-Injectors

  • OPA Bulletin - February 19, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • U of T startup raises $3.25 million to eliminate prescription opioids after surgery
    • The Future of the Profession - Pharmacy in the 21st Century
    • New Horizons in Pharmacy - Register for OPA's free webinar

    • Asthma Management: The Essentials
    • Drugs in Chronic Kidney Disease
    • Pharmacist Health Coaching – Cardiovascular Program Training Course

    • Who best to nominate you for the OPA Patient Impact Award than your patients?
    • Ask the Practice Support Network
    • Insurance Highlight: Is your store's insurance enough protection for you?
    • Learn about the Insurance Committee's work on your behalf to ensure you are supported

    • Drug Shortage Health System Alert: Potassium Chloride

    • DDD Notice No. 19035 posted February 19, 2019 HEALTH NETWORK SYSTEM (HNS) AND NARCOTICS MONITORING SYSTEM (NMS) OUTAGE NOTIFICATION TO ODP AGENCIES
    • DDD Notice No. 19034 posted February 15, 2019 Prescription Forgery Alert
    • DDD Notice No.19031 posted February 14, 2019 Prescription Forgery Alert
    • DDD Notice No.19030 posted February 13, 2019 Prescription Forgery Alert
    • DDD Notice No.19029 posted February 13, 2019 Prescription Forgery Alert
    • DDD Notice No.19028 posted February 13, 2019 Prescription Forgery Alert

    • Health Canada recommends that children and youth not use cough and cold products that contain opioids

  • eDIRC: New Patient Information Sheets Available!

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    February 14, 2019 volume 17 no 4

  • OPA Bulletin - February 12, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Health Canada updates to opioid prescriptions
    • Evaluation of the fentanyl patch-for-patch program in Ontario
    • Non-Insured Health Benefits (NIHB) Program Notice
    • Notification from Pfizer: Supply Interruptions – ZINECARD, 250 mg

    • CDE Exam Preparation Course March 2-3, 2019
    • Identifying Drug Interactions
    • Point of Care Screening Programs in Community Pharmacy

    • New Horizons in Pharmacy - Webinars with OPA Leadership
    • Ask the Customer Experience and Administration Team
    • Insurance Highlight: Q&A on the OPA Secure Health Plan
    • OPA Cup - Celebrate Pharmacist Awareness Month and support your team!
    • ICYMI: Have you seen our insurance product videos?

    • Health Canada updating safety review of breast implants

  • OPA Bulletin - February 5, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: OPA recommendations to OHIP+ consultation
    • ICYMI: OPA news release supporting "Devlin" report on Improving Health Care and Ending Hallway Medicine
    • Have you got what it takes? OPA is hiring a new CEO!
    • Research position with Ontario Pharmacy Evidence Network (OPEN)

    • CDE Exam Preparation Course March 2-3, 2019
    • Third Party Audits: An Introduction
    • Selling What You Can Do For Your Clients

    • What our members are saying
    • Ask the Practice Support Network
    • Insurance Highlight: Have you protected what pays for your car, home, and everything else? Watch our video.

    • DDD Notice No. 19024 posted February 4, 2019 Notice from the Executive Officer
    • DDD Notice No. 19023 posted February 1, 2019 Prescription Forgery Alert
    • DDD Notice No. 19022 posted January 31, 2019 Notice from the Executive Officer
    • DDD Notice No. 19021 posted January 30, 2019 Prescription Forgery Alert

  • eDIRC: Tool To Helps Patients Swallow Pills

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    January 31, 2019 volume 17 no 3

  • OPA Bulletin - January 29, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Important deadline approaching for PLI insurance
    • Bell Let's Talk Day resources and information for pharmacy
    • Health Canada resources for managing opioids
    • Pain competence assessment tool (PCAT) survey from the Musculoskeletal Program at Toronto Rehabilitation Institute (TRI)
    • New tool for veterinary antimicrobial sales reporting

    • FREE! New live opioid webinars - four sessions to choose from
    • 2019 Board Certified Geriatric Pharmacist Exam Prep Course - online
    • CV Health Coaching for Pharmacists – Cardiovascular Training

    • Who best to nominate you for the OPA Patient Impact Award than your patients?
    • Ask the Customer Experience and Administration Team
    • Insurance Highlight: Why do I need disability insurance?
    • Winter promotion - OPA members receive 20% off admission to Museum of Illusions
    • Last week for eBulletin and eDIRC for those who have not renewed their membership or subscription

    • DDD Notice No. 19020 posted January 28, 2019 Prescription Forgery Alert
    • DDD Notice No. 19019 posted January 23, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – January 2019
    • DDD Notice No. 19018 posted January 23, 2019 Prescription Forgery Alert

Back to top